Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/281814
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2020-03-16T05:42:27Z-
dc.date.available2020-03-16T05:42:27Z-
dc.identifier.urihttp://hdl.handle.net/10603/281814-
dc.description.abstractThe present investigation was aimed to develop a targeted co-delivery system of paclitaxel (PAX) and clotrimazole (CLZ) through polycaprolactone (PCL) nanoparticles (NPs). Sialic acid (SA) was employed to acquire active targeting towards breast cancer cells. To accomplish this objective, initially, we optimized the concentration of PAX and CLZ by determining cell viability through MTT assay. CompuSyn software was used to depict the synergistic, additive or antagonist effect of PAX and CLZ in combination. MTT assay and CompuSyn simulations suggest the synergistic activity of PAX and CLZ at 12.5-nM and 25-and#956;M respectively and nominated as PACL. Fluorescent microscopy also supports our finding, where PACL significantly induced nuclear damage in breast cancer cells (MCF-7 and MDA-MB-231). Oxidative stress and nitrogen stress was also aggravated by PACL when compared to individual drug concentration. PACL exhibited significant genotoxicity in cancerous cells whereas glucose uptake was inhibited remarkably through PACL in contrast to individual drug concentration. The second objective was to formulated surface functionalized SA polymeric nanoparticles (SA-PCL-NPs) of PAX. Carbodiimide reaction was exploited to mount SA on the surface of PCL-NPs. Characterisation reveals that SA-PCL-NPs were having spherical morphology with a size range of 151.5 nm to 179.47 nm. SA-PCL-NPs profoundly homed themselves inside the cancer cells and induces apoptosis as suggested by MTT assay and photoluminescence study. newlineWhile in the third objective different variables, that play an integral role in the development of nano-formulation were optimized through response surface methodology (RSM). Box Behnken Design (BBD) was employed to generate 3-dimensional surface plots and further analyzed to study the effect of variables on the particle size (PS) and entrapment efficiency % (%EE). Results suggest that when the optimized concentration of variables will be used, there would be 92.4% chances to get PS of 178.7 nm and %EE of 49.13% and witnessed that
dc.format.extentxxvii, 133p
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleDevelopment of Targeted Drug Delivery System for Breast Cancer
dc.title.alternative
dc.creator.researcherSharma, Arun
dc.subject.keywordBreast Cancer
dc.subject.keywordClinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
dc.subject.keywordClotrimazole
dc.subject.keywordCytotoxicity
dc.subject.keywordDrug delivery
dc.subject.keywordDrug release
dc.subject.keywordNano-formulation
dc.subject.keywordPaclitaxel
dc.description.note
dc.contributor.guideMalairaman, Udayabanu
dc.publisher.placeSolan
dc.publisher.universityJaypee University of Information Technology, Solan
dc.publisher.institutionDepartment of Pharmacy
dc.date.registered05/08/2013
dc.date.completed2020
dc.date.awarded10/02/2020
dc.format.dimensions
dc.format.accompanyingmaterialDVD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File29.46 kBAdobe PDFView/Open
02_certificate;declaration;acknowledgement.pdf780.52 kBAdobe PDFView/Open
03_table of contents;list of tables & figures; abb;abstract.pdf570.87 kBAdobe PDFView/Open
04_chapter 1.pdf4.18 MBAdobe PDFView/Open
05_ chapter 2.pdf1.29 MBAdobe PDFView/Open
06_chapter 3.pdf1.01 MBAdobe PDFView/Open
07_ chapter 4.pdf1.11 MBAdobe PDFView/Open
08_ chapter 5.pdf1.02 MBAdobe PDFView/Open
09_appendix.pdf902.94 kBAdobe PDFView/Open
10_reference.pdf235.24 kBAdobe PDFView/Open


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: